P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

November 2005

Features

Consensus Recommendations for the Off-Label Use of Recombinant Human Factor VIIa (NovoSeven®) Therapy

An expert panel suggests setting limits on recombinant human factor VII (rFVIIa, NovoSeven®) therapy for bleeding because of concerns about its safety, effectiveness, and cost.
Aryeh Shander, MD, Lawrence Tim Goodnough, MD, Thomas Ratko, PhD, Karl A. Matuszewski, MS, PharmD, Stephen Cohn, MD, Michael Diringer, MD, Henry Edmunds, MD, Jeffrey Lawson, MD, PhD, Robert MacLaren, PharmD, Paul Ness, MD, Roger Shere-Wolfe, MD, JD, and Robert Dubois, MD

Commentary

Pharmacogenomics: Going Down the Rabbit Hole

Ms. Pauli reflects on a paradigm shift that is taking place in drug development and patient care: from global treatment modalities to more individualized therapeutics based on genomic data.
Emily K. Pauli, BS, BMS, PharmD Candidate

A Real Y2K for Medicaid P&T Committees

The authors offer a preview of what will take place for “dual eligibles,” whose costs for prescription drugs were covered by both Medicaid and Medicare, as they are transferred from Medicaid to the new Medicare drug plans in 2006.
Richard Stefanacci, DO, MGH, MBA, AGSF, CMD, and Steven L. Phillips, MD, CMD

Pharmaceutical Approval Update

Dr. Goldenberg reviews exemestane (Aromasin®) for treating estrogen receptor–positive breast cancer; a vaccine (Proquad®) for protection against measles, mumps, rubella, and chickenpox in children; and a vaccine (Fluarix™) for immunization against influenza virus types A and B in adults.
Marvin M. Goldenberg, PhD, RPh, MS

Meeting Highlights

130th Annual Meeting of the American Neurological Association

Therapies for migraine, multiple sclerosis, Parkinson’s disease, diabetic peripheral neuropathy, agitation, Alzheimer’s disease, and other disorders are presented.
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Departments

Editorial

Best Buy Drugs

David Nash, MD, MBA, discusses a new Web site called “Best Buy Drugs,” a project of Consumer Reports magazine.
David B. Nash, MD, MBA

Medication Errors

Watch Out for This Turkey — Complacency

Matthew Grissinger, RPh, FASCP, reviews some of the dangers of complacency on the job, especially when automation or technology is present.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Building a Safety Nest for Avian Flu: Government Moving Slowly on Twig Collection

Stephen Barlas outlines the preparatory steps the government is taking, albeit slowly, to avoid an avian influenza pandemic.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest studies and information about FDA approvals, drug indications, industry updates, and new devices.

Drug Forecast

Abatacept (CTLA4-Ig, Orencia): An Investigational Biological Compound for the Treatment of Rheumatoid Arthritis

The authors review the benefits of abatacept (CTLA4-Ig, Orencia), an investigational compound for the treatment of rheumatoid arthritis.
Payam Parchamazad, PharmD Candidate, Patty Ghazvini, PharmD, Marlon Honeywell, PharmD, and Phillip Treadwell, PharmD